Related Experiment Videos

Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory

Sung Wook Seo1, Daniel Lee, Hiroshi Minematsu

  • 1Department of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea.

Bone
|November 10, 2009
PubMed

Insights

The extracellular signal-regulated kinase (ERK) pathway drives inflammatory osteolysis by activating M-CSF in response to LPS. Inhibiting ERK signaling reduces this inflammatory response, suggesting ERK as a therapeutic target for osteolysis.

Area of Science:

  • Cell Biology
  • Immunology
  • Skeletal Biology

Background:

  • The extracellular signal-regulated kinase 1/2 (ERK) pathway, a key component of the mitogen-activated protein kinase (MAPK) family, is crucial for cell differentiation and proliferation.
  • Macrophage colony stimulating factor (M-CSF) activates ERK signaling, promoting osteoclast precursor survival during osteoclastogenesis.

Purpose of the Study:

  • To investigate the role of the ERK signaling pathway in mediating inflammatory osteolysis.
  • To determine if ERK signaling is involved in the innate immune response of osteoblasts to lipopolysaccharide (LPS).

Main Methods:

  • Utilized both in vivo and in vitro experimental models.
  • Investigated the expression of M-CSF in osteoblasts in response to LPS.
  • Examined the effect of ERK signaling inhibition on inflammatory responses.

Main Results:

  • Demonstrated that the ERK signaling pathway is implicated in the inflammatory response driving osteolysis.
  • Showed that LPS-induced M-CSF expression in osteoblasts is mediated by ERK.
  • Confirmed that inhibiting ERK signaling attenuates the inflammatory response to LPS in both in vivo and in vitro settings.

Conclusions:

  • The ERK pathway plays a significant role in mediating inflammatory osteolysis.
  • ERK signaling is a critical component of the osteoblast innate immune response to LPS.
  • Targeting the ERK pathway presents a potential therapeutic strategy for managing inflammatory osteolysis.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...